暂无数据
代码股票名称
最新价涨跌额涨跌幅成交量成交额今开昨收最高最低总市值流通市值总股本流通股本5日涨跌幅10日涨跌幅20日涨跌幅60日涨跌幅120日涨跌幅250日涨跌幅年初至今涨跌幅股息率TTM换手率市盈率TTM市盈率(静)振幅所属行业
美股期权个股详情
OLN240517C30000
- 26.35
- -3.45-11.58%
延时15分钟行情交易中 05/17 12:44 (美东)
26.35最高价26.35最低价
26.35今开29.80昨收2张成交量2张未平仓合约数30.00行权价5270.00成交额939.88%隐含波动率0.28%溢价2024/05/17到期日26.09内在价值100合约乘数0天距到期日0.26时间价值100合约规模美式期权类型0.9845Delta0.0022Gamma2.14杠杆倍数-0.7852Theta0.0003Rho2.10有效杠杆0.0007Vega
分时
- 5日
- 日K
新闻
格隆汇5月15日｜欧林生物公告，四价流感病毒裂解疫苗(MDCK细胞)获得药物临床试验批准通知书。
格隆汇5月15日｜欧林生物公告，四价流感病毒裂解疫苗(MDCK细胞)获得药物临床试验批准通知书。
成都欧林生物科技股份有限公司药品申请临床试验默示许可获受理
5月15日，据CDE官网消息，成都新诺明生物科技有限公司、成都欧林生物科技股份有限公司、兰州百灵生物技术有限公司联合申请药品“四价流感病毒裂解疫苗（MDCK细胞）”，获得临床试验默示许可，受理号CXSL2400138。公示信息显示，药品“四价流感病毒裂解疫苗（MDCK细胞）”适应症：用于预防疫苗相关型别流感病毒引起的流行性感冒。
Olin Insiders出售了2200万美元的股票，这表明他们犹豫不决
在过去的一年中，许多奥林公司（纽约证券交易所代码：OLN）内部人士抛售了股票，这可能会引起该公司的股东的兴趣。在分析内幕交易时，通常更有价值
快讯 | 纽约证券交易所订单不平衡买入方有96764.0股票
欧林生物核心技术人员李洪光减持0.20万股，成交均价9.71元
上交所公开信息显示，5月7日，欧林生物核心技术人员李洪光在二级市场买卖公司股票，减持股数0.20万股，成交均价9.71元，变动金额19.42万元元，变动后持股数为19.42万元。近一个月来，欧林生物共出现1次高管增持，增持总数8.00万股。欧林生物共出现2次高管减持，减持总数4.00万股。
奥林公司的股息分析
评论
Olin's capital allocation skills are strong, yielding higher returns from less capital. The stock's 159% return over five years suggests investors acknowledge these positive changes. If trends persist, Olin's future looks promising.
The Return Trends At Olin (NYSE:OLN) Look Promising 1
The shift from loss to profitability is generally seen as a positive sign, which would typically lead to an increasing share price. Despite the recent downturn, long-term shareholders have made an annual gain of 18% over half a decade. If the fundamental data continues to indicate long term sustainable growth, the current sell-off could be an opportunity worth considering.
Scott Sutton's recent sale of Olin shares is the largest insider sale in the past year. The sale's timing, around the current price, is neither alarming nor encouraging. The absence of insider purchases over the year and low insider ownership raise caution about the company.
1
Olin's diminishing earnings predict a possible decline in the P/E ratio. Investors see a low potential for earnings improvement, suggesting share price might not increase extensively in the near future.
Morning Movers
Gapping up
$美国超微公司(AMD.US$ Shares of the chipmaker rose 2% in premarket trading as investors digested the details of the new Instinct MI300X product that AMD unveiled on Wednesday afternoon. The chip is designed to take advantage of the boom in demand for computing power from artificial intelligence.
$捷蓝航空(JBLU.US$ on Thursday narrowed its annual adjusted loss forecast, riding on st...
Gapping up
$美国超微公司(AMD.US$ Shares of the chipmaker rose 2% in premarket trading as investors digested the details of the new Instinct MI300X product that AMD unveiled on Wednesday afternoon. The chip is designed to take advantage of the boom in demand for computing power from artificial intelligence.
$捷蓝航空(JBLU.US$ on Thursday narrowed its annual adjusted loss forecast, riding on st...
12
1
阅读更多